Anavex Life Sciences SG&A Expense (Quarterly) Trends

Anavex Life Sciences Corp (AVXL)

3.89 +0.18 (+4.85%) USD | NASDAQ | May 09, 16:00

3.92 +0.03 (+0.77%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2004. Upgrade now.

Date	Value
December 31, 2023	2.609M
September 30, 2023	2.592M
June 30, 2023	3.248M
March 31, 2023	2.883M
December 31, 2022	3.317M
September 30, 2022	3.902M
June 30, 2022	3.186M
March 31, 2022	2.915M
December 31, 2021	3.067M
September 30, 2021	2.880M
June 30, 2021	2.434M
March 31, 2021	2.234M
December 31, 2020	1.471M
September 30, 2020	1.403M
June 30, 2020	1.382M
March 31, 2020	1.720M
December 31, 2019	1.352M
September 30, 2019	1.635M
June 30, 2019	1.389M
March 31, 2019	2.061M
December 31, 2018	1.761M
September 30, 2018	1.482M
June 30, 2018	1.620M
March 31, 2018	1.489M
December 31, 2017	1.398M

Date	Value
September 30, 2017	1.361M
June 30, 2017	1.405M
March 31, 2017	1.116M
December 31, 2016	1.126M
September 30, 2016	3.217M
June 30, 2016	1.135M
March 31, 2016	1.090M
December 31, 2015	3.369M
September 30, 2015	3.220M
June 30, 2015	0.7135M
March 31, 2015	0.4512M
December 31, 2014	0.4521M
September 30, 2014	0.2953M
June 30, 2014	0.7338M
March 31, 2014	0.903M
December 31, 2013	0.3044M
September 30, 2013	1.371M
June 30, 2013	0.087M
March 31, 2013	0.1266M
December 31, 2012	0.2879M
September 30, 2012	0.528M
June 30, 2012	0.3019M
March 31, 2012	0.3646M
December 31, 2011	0.4685M
September 30, 2011	0.6322M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

1.352M

Minimum

Dec 2019

3.902M

Maximum

Sep 2022

2.401M

Average

2.592M

Median

Sep 2023

SG&A Expense (Quarterly) Benchmarks